Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
37.33
-0.04 (-0.11%)
At close: Dec 23, 2025, 4:00 PM EST
38.90
+1.57 (4.21%)
Pre-market: Dec 24, 2025, 8:49 AM EST
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $792.08 million as of December 24, 2025. Its market cap has increased by 199.83% in one year.
Market Cap
792.08M
Enterprise Value
516.74M
1-Year Change
199.83%
Ranking
Category
Stock Price
$37.33
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $792.08M, a decrease of -80.81%. That is a compound annual growth rate of -30.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 792.08M | 323.61% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | 4.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |